Article
Phosphorylated AKT expression is associated with PIK3CA mutation, low stage, and favorable outcome in 717 colorectal cancers.
Cancer - 1 Apr 2011
Baba Yoshifumi, Nosho Katsuhiko, Shima Kaori, Hayashi Marika, Meyerhardt Jeffrey A, Chan Andrew T, Giovannucci Edward, Fuchs Charles S, Ogino Shuji
Abstract excerpt
BACKGROUND: AKT (AKT1, AKT2, and AKT3) was a downstream effector of phosphatidylinositide-3-kinase (PI3K) and played crucial roles in protein synthesis, cellular metabolism, survival, and proliferation. The PI3K/AKT pathway was commonly activated in human cancers and was recognized as a potential target for anticancer therapy. Nonetheless, clinical, molecular, or prognostic features of AKT-activated colon cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
